scispace - formally typeset
J

Jagtar Singh

Researcher at Panjab University, Chandigarh

Publications -  95
Citations -  944

Jagtar Singh is an academic researcher from Panjab University, Chandigarh. The author has contributed to research in topics: Genotype & Asthma. The author has an hindex of 14, co-authored 86 publications receiving 742 citations. Previous affiliations of Jagtar Singh include Allahabad University & Loughborough University.

Papers
More filters
Journal ArticleDOI

Metagenomics: Concept, methodology, ecological inference and recent advances

TL;DR: In this paper, a review describes the various methodologies and tools developed to understand the biology of uncultured microbes including bacteria, archaea and viruses through metagenomic analysis.
Journal ArticleDOI

Production and characterization of a thermostable β-galactosidase from Bacillus coagulans RCS3

TL;DR: A strain of Bacillus coagulans RCS3 isolated from ahot‐water spring produced significant β‐galactosidase activity at 10 days of growth in a flask, suggesting that 63 °C is the temperature of preference compared with 65 °C for a combination of good activity and stability.
Journal ArticleDOI

A study on the epidemiology of brucellosis in Punjab (India) using Survey Toolbox.

TL;DR: A random survey was conducted to study the epidemiology of brucellosis in Punjab (India), using the 'Survey Toolbox' sampling software, and the seroprevalence of bru cellosis was found to be significantly higher in animals with a history of abortion than in those without such a history.
Journal ArticleDOI

Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity

TL;DR: Genetic polymorphisms of the NAT2 and CYP2E1 genes were studied and slow phenotype of NAT2 was found to be a risk factor for developing ATDH when compared to fast acetylators and 'c2' allele absence in females ATDH group can be considered as a protective factor against development of ATDH.
Journal ArticleDOI

Microbial production and biotechnological applications of α-galactosidase

TL;DR: This ubiquitous enzyme has been vastly commercialized and holds greater future prospects, including therapeutic advances in treatment of Fabry disease, blood group conversion and removal of α-gal type immunogenic epitopes in xenotransplantation.